Camrelizumab Combination With SBRT and Concurrent Chemotherapy Treated Stage IV Oligometastatic Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Chemotherapy
Related studies linked through entity extraction aliases.
Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Intraperitoneal Chemotherapy Versus Triweekly Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
Induction FOLFIRINOX Followed by Chemoradiation in Locally Advanced Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients
- Status
- RECRUITING
- Phase
- NA
Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma
- Status
- COMPLETED
- Phase
- N/A
WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
- Status
- RECRUITING
- Phase
- PHASE3
Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
- Status
- UNKNOWN
- Phase
- N/A
Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
ChemoRadiation And Tislelizumab for Esophageal/EGJ Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Sintilimab Plus NCT or NCRT Versus NCRT for ESCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study of AK112 in Advanced Malignant Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2